NORFLOXACIN pharmaceutical API fine chemical sources

Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
ChemExper Chemical Directory	⤷ Start Trial	jnsqb@BVBzkPRFQQQJIIIQZXjLdXOhpPTUSUTqH@@	⤷ Start Trial
NovoSeek	⤷ Start Trial	4539	⤷ Start Trial
Vitas-M Laboratory	⤷ Start Trial	STK177250	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: July 28, 2025

Introduction

Norfloxacin, a first-generation fluoroquinolone antibiotic, is used extensively to treat urinary tract infections, prostatitis, and other bacterial infections [1]. The global demand for Norfloxacin necessitates a reliable and compliant supply chain of high-quality Active Pharmaceutical Ingredients (APIs). This article provides a comprehensive overview of primary sources for bulk Norfloxacin APIs, focusing on manufacturing regions, key suppliers, quality considerations, and supply chain dynamics.

Manufacturing Regions for Norfloxacin API

Historically, the production of Norfloxacin API has concentrated among several prominent regions with established pharmaceutical manufacturing hubs:

India: Dominates the global API market for antibiotics, including Norfloxacin, owing to its well-developed pharmaceutical industry, cost-effectiveness, and manufacturing scale [2].
China: A significant player, China offers a large pool of API manufacturers leveraging advanced synthesis technologies and expansive production capacity [3].
Europe: While less dominant in bulk API production for Norfloxacin, Europe provides high-quality APIs, especially for clients demanding stringent regulatory compliance.
United States: Generally relies on imports; domestic production of Norfloxacin API is minimal, primarily due to reliance on overseas suppliers.

Key Suppliers and Manufacturers

Indian API Manufacturers

India remains the foremost source for Norfloxacin APIs, with multiple WHO-GMP and US-FDA approved facilities. Notable companies include:

Sun Pharmaceutical Industries Ltd.: One of the largest generic pharmaceutical manufacturers globally, with certified API production lines including Norfloxacin [4].
Aarti Industries Ltd.: Manufactures bulk APIs with stringent quality controls, supplying to both domestic and international markets [5].
Glenmark Pharmaceuticals: Active in API manufacturing, including fluoroquinolones, with a focus on quality compliance and manufacturing efficiency [6].
Biophore: Specializes in high-quality generic APIs, including Norfloxacin, with regulatory approvals for export.

Chinese API Manufacturers

Hubei Rooks Biotechnology Co., Ltd.: Offers bulk API production, with a focus on antibiotic molecules including Norfloxacin [7].
Shandong Lanhang Pharmaceutical Co., Ltd.: Engaged in API synthesis, aiming at export markets with competitive pricing.
Jiangxi United States Pharmaceutical Co., Ltd.: Supplies APIs compliant with international standards.

European and US Suppliers

While fewer in number, some European and US-based firms offer Norfloxacin APIs through partnerships or direct supply:

Antibiotice Iasi (Romania): Offers high-quality antibiotics including Norfloxacin with compliance to European standards.
Ajinomoto Bio-Pharma Services (USA): Provides custom manufacturing services, including API synthesis for specialty markets.

Quality and Regulatory Considerations

API sourcing for Norfloxacin requires comprehensive vetting due to strict regulatory standards. Key factors include:

GMP Compliance: Suppliers must adhere to Good Manufacturing Practices, verified via audits and certifications.
Regulatory Approvals: Certificates of Suitability (CE) from the European Directorate for the Quality of Medicines & HealthCare (EDQM), Drug Master Files (DMFs), and approval by agencies such as the US FDA are critical quality indicators.
Batch Consistency & Purity: API specifications typically require >99% purity, low residual solvents, and compliance with pharmacopeial standards such as USP or EP.
Traceability & Supply Chain Security: Due diligence on supply chain transparency remains vital in mitigating risks associated with counterfeit or substandard APIs.

Supply Chain Dynamics and Market Trends

The API market for Norfloxacin faces evolving challenges:

Cost Pressures: Indian and Chinese suppliers offer competitive pricing, essential for large-scale manufacturing. However, price negotiations must balance quality and regulatory compliance.
Regulatory Stringency: Increasingquality standards have led to the closure of substandard API facilities, impacting supply availability.
Geopolitical Factors: US-China trade tensions and India's export policies influence supply chain stability.
Environmental Concerns: Regulatory trend toward stringent environmental controls affects manufacturing processes in China and India, possibly impacting supply capacity.

Emerging Trends

Shift to Contract Manufacturing Organizations (CMOs): Pharmaceutical companies increasingly partner with specialized CMOs to ensure quality and supply security.
Development of API Portfolios: Suppliers expanding their portfolios to include both generic and proprietary formulations can offer integrated solutions.
Advanced Synthesis Technologies: Use of green chemistry and improved synthetic pathways reduces impurities and environmental impact.
Regional Diversification: Companies seek to diversify supply sources to mitigate geopolitical risks.

Key Takeaways

India and China dominate as primary sources of Norfloxacin API, offering affordability and capacity.
Regulatory compliance, including GMP standards and international certifications, is paramount in API sourcing.
Quality assurance, traceability, and transparency are essential to mitigate counterfeiting and ensure drug safety.
Market dynamics are influenced by regulatory trends, environmental controls, and geopolitical factors, affecting supply stability.
Strategic partnerships with reputable, certified API manufacturers enhance supply security and product quality.

FAQs

1. What are the primary regions producing Norfloxacin API globally?
India and China are the leading regions, with established manufacturing capacities and certifications. Europe and the US primarily import APIs, with limited domestic production.

2. How can I verify the quality of a Norfloxacin API supplier?
Verify GMP certification, review regulatory approvals such as EDQM Certificates of Suitability or DMFs, and conduct audits or request detailed quality documentation.

3. What are the common specifications for Norfloxacin API?
Typically, >99% purity, compliant residual solvent levels per ICH guidelines, and conformity with USP/EP standards.

4. How do geopolitical factors impact API supply chains for Norfloxacin?
Trade tensions and export restrictions can disrupt supply lines, prompting manufacturers to diversify sourcing and strengthen regional supply.

5. Is it better to source Norfloxacin API from established global suppliers or emerging manufacturers?
Prioritize established suppliers with proven regulatory compliance and quality certifications. Emerging manufacturers require thorough due diligence.

References

[1] World Health Organization. The Use of Antibiotics in Human Medicine. 2020.
[2] IQVIA. Global API Market Report 2022.
[3] China药典. API Manufacturing Standards. 2021.
[4] Sun Pharmaceutical Industries Ltd. Corporate Website.
[5] Aarti Industries Ltd. Annual Report 2022.
[6] Glenmark Pharmaceuticals. API Portfolio.
[7] Hubei Rooks Biotechnology Product Profiles.

This analysis aims to inform pharmaceutical and supply chain decision-makers seeking reliable sources for Norfloxacin API, emphasizing regulatory compliance, quality assurance, and market trends.

Bulk Pharmaceutical API Sources for norfloxacin